Trials / Completed
CompletedNCT02181530
Retrospective Data Collection Study in Patients With Macular Oedema Receiving OZURDEX®
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 43 (actual)
- Sponsor
- Allergan · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This study will use retrospective data to evaluate the safety and efficacy of OZURDEX® (dexamethasone intravitreal implant 0.7 mg) in the treatment of macular oedema due to retinal vein occlusion (RVO) in clinical practice. No intervention will be administered as part of this study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No Intervention | No treatment (intervention) is being administered as part of this study. |
Timeline
- Start date
- 2014-07-01
- Primary completion
- 2014-10-01
- Completion
- 2014-10-01
- First posted
- 2014-07-04
- Last updated
- 2015-05-25
- Results posted
- 2015-05-25
Locations
1 site across 1 country: Poland
Source: ClinicalTrials.gov record NCT02181530. Inclusion in this directory is not an endorsement.